Form 4: Lexeo Therapeutics CLO Sells Shares for Tax Obligations

Lexeo Therapeutics' Chief Legal Officer, Jenny Robertson, sold 549 shares of common stock to cover tax obligations related to restricted stock units.

Summary

• Jenny Robertson, Chief Legal Officer of Lexeo Therapeutics, Inc. (LXEO), reported a sale of common stock.
• The transaction occurred on November 18, 2025, and involved the disposition of 549 shares.
• The shares were sold at a weighted average price of $9.27 per share, with individual trades ranging from $9.09 to $9.37.
• The purpose of this sale was to cover tax obligations arising from the release of restricted stock units (RSUs).
• Following this transaction, Jenny Robertson beneficially owns 68,381 shares of Lexeo Therapeutics common stock, which includes 49,607 RSUs.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, pre-planned transaction by an insider to cover tax obligations upon the vesting of restricted stock units, not indicative of a change in company fundamentals or insider sentiment.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine insider transaction, common across all industries, where executives sell shares to cover tax liabilities upon the vesting of equity awards. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a small, routine transaction for tax purposes and does not signal a change in the company's operational or financial health.

Key Dates

Recommendation

The filing reports a routine, pre-planned sale of shares by a company officer to cover tax obligations upon the vesting of restricted stock units. This transaction does not reflect a change in the officer's overall investment sentiment or the company's fundamentals, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

Lexeo Therapeutics, LXEO, Jenny Robertson, Chief Legal Officer, insider transaction, Form 4, stock sale, RSU, tax obligations